Get started
Author

Shruti K. Dharmadhikari

Observed names: Gaurav Puppalwar, SHRUTI DHARMADHIKARI, Shruti Dharmadhikari
Institution: Sun Pharma (India)
ORCID: 0000-0002-2249-2662
Observed ORCID: 0000-0002-2249-2662
OpenAlex ID: A5091722600
Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring
2016 · Anil K. Pareek, Franz H. Messerli, et al. · Journal of the American College of Cardiology · 105
PDF
A review on the pharmacology of cariprazine and its role in the treatment of negative symptoms of schizophrenia
2024 · Panneer Selvan, Prashant Devkare, et al. · Frontiers in Psychiatry · 24
PDF
Efficacy and Safety of Pregabalin Prolonged Release–Etoricoxib Combination Compared to Etoricoxib for Chronic Low Back Pain: Phase 3, Randomized Study
2022 · Amit B. Yeole, G. Sree Ranga Lakshmi, et al. · Pain and Therapy · 11
PDF
Effectiveness of Oral Cephalexin-Clavulanic Acid, Cefuroxime, and Amoxicillin-Clavulanic Acid in the Management of Dental Infections: A Real-World, Retrospective, Electronic Medical Record-Based Study in India
2023 · Kalyan Banerjee, Ajay Kakkar, et al. · Drugs - Real World Outcomes · 10
PDF
Congestive heart failure: More common as well as an important cardiovascular outcome
2016 · Anil Pareek, Nitin Chandurkar, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 7
PDF
A Comprehensive Review of the Clinical Evidence on the Efficacy, Effectiveness, and Safety of Silodosin for the Treatment of Benign Prostatic Hyperplasia
2025 · Omar S Akhtar, Vishal Singh, et al. · Cureus · 6
PDF
Efficacy and Safety of a Topical Formulation Containing Trihydroxybenzoic Acid Glucoside and α‐Arbutin, Applied Along With a Sunscreen: A Noncomparative, Prospective, Interventional Study in Indian Females With Facial Melasma or Dark Spots
2025 · Mukesh Gabhane, Raji Patil, et al. · Journal of Cosmetic Dermatology · 4
PDF
Assessment of Burden of Partial Response to Standard Doses of Proton Pump Inhibitors in Patients with Clinically Diagnosed Gastroesophageal Reflux Disease: A Real-World Evidence Study in India
2025 · Yogesh Garje, Rajiv Saikia, et al. · Drugs - Real World Outcomes · 3
PDF
Sitagliptin as an Add-on Therapy to Other Glucose-lowering Agents in Patients with Type 2 Diabetes Mellitus: A Narrative Review.
2025 · Sanjay Kalra, Awadhesh Kumar Singh, et al. · PubMed · 3
Compelling therapy of LVH: straight (and not-so-straight) inferences from evidence
2019 · Ravi Tejraj Mehta, Anil Pareek, et al. · Clinical Hypertension · 3
PDF
Optimising TRIUMPH with 6·25 mg chlorthalidone
2020 · Anil Pareek, C Venkata S Ram, et al. · The Lancet Global Health · 2
PDF
Drug Utilization Pattern of Proton Pump Inhibitors in Patients with Acid Peptic Disease and Comorbidities in India: A Real-World Electronic Medical Records-Based Study
2026 · Yogesh Garje, Tanish Modi, et al. · Drugs - Real World Outcomes · 1
A comparative pharmacokinetic evaluation of two aqueous progesterone 25 mg injections in healthy postmenopausal women under fasting conditions: An open‐label, balanced, randomized, two‐treatment, two‐period, two‐sequence, single‐dose, crossover bioequivalence study
2026 · Noopur Vyas, Amaresh Chakra, et al. · Clinical Pharmacology in Drug Development · 1
PDF
Assessment of Atherosclerotic Cardiovascular Disease Risk using Atherosclerotic Cardiovascular Disease Risk Estimator Plus in Indian Patients – A Real-world, Retrospective Study from Electronic Medical Records
2024 · Ramnaresh Soudri, Shruti Dharmadhikari, et al. · Indian Heart Journal · 1
Real-world effectiveness of dapagliflozin and sitagliptin fixed-dose combination in indian patients with type 2 diabetes: a retrospective analysis of electronic medical records stratified by BMI
2024 · Rajiv Kovil, Rajesh Deshmane, et al. · Endocrine Abstracts · 1
The Efficacy and Safety of High Dose (10 mg) of Desloratadine (Dazit® 10) in the Treatment of Chronic Spontaneous Urticaria in India: A Phase III, Multicentric, Open-Label, Single-Arm Study
2024 · Saurabh Kapadia, Siddabathuni Nageswaramma, et al. · Cureus · 1
PDF
Risk vs Benefits of Thiazides in Clinical Use: Need for a Holistic Approach
2022 · Anil Pareek, Nitin Chandurkar, et al. · The American Journal of Medicine · 1
PDF
SGLT2 inhibitor/GLP-1 receptor agonists as first step monotherapy—evidence and implications
2020 · Anil Pareek, Ravi T. Mehta, et al. · International Journal of Diabetes in Developing Countries · 1
1084-P: Postmarketing Real-World Effectiveness of Hydroxychloroquine (HCQ) in Treatment of Patients with T2D
2020 · ANIL PAREEK, SHRUTI DHARMADHIKARI, et al. · Diabetes · 1
1167-P: Safety and Efficacy of 52 Weeks' Therapy with Hydroxychloroquine (HCQ)—First Anti-inflammatory Drug Approved in India for T2D
2019 · ANIL PAREEK, RAVI TEJRAJ MEHTA, et al. · Diabetes · 1
Comment on: Incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine
2019 · Anil Pareek, Ravi Tejraj Mehta, et al. · Rheumatology Advances in Practice · 1
PDF
CONTROL-IHD Study: 24-h BP Control with Metoprolol-Telmisartan FDC in Hypertension and Stable Ischemic Disease
2026 · Kamal Sharma, Gaurav Chhaya, et al. · Advances in Therapy
PDF
Correction: Effectiveness and Tolerability of Low-Dose Micronized Isotretinoin in Patients with Severe Recalcitrant Nodular Facial Acne in India: A Real-World Retrospective Study Using Electronic Medical Records
2026 · Byalakere S. Chandrashekar, Maya Vedamurthy, et al. · Dermatology and Therapy
PDF
Evaluating the Therapeutic Potential of Antioxidants in Polyendocrine Metabolic Ovarian Syndrome (PMOS)-Associated Infertility
2026 · Pramathes Das Mahapatra, Vidya Vishwanath Bhat, et al. · International Journal of Women s Health
PDF
Correction: Drug Utilization Pattern of Proton Pump Inhibitors in Patients with Acid Peptic Disease and Comorbidities in India: A Real-World Electronic Medical Records-Based Study
2026 · Yogesh Garje, Tanish Modi, et al. · Drugs - Real World Outcomes
PDF
Works count: 55
Citation count: 188
H-index: 6
I10-index: 4
Year
Topic
Type